Would a LIMS or SAP better meet the needs of your company? In this whitepaper, we will take a look at the different systems on the market for managing laboratory operations.
White Papers
27 May 2020
Digital Transformation is taking hold in the pharmaceutical industry. It is no longer an innovative vision, but a strategic imperative for companies to vying to remain competitive.
04 May 2020
With flexible options to meet budgetary requirements, world class infrastructure, fully managed services and the benefits of organizational synergy, Abbott Informatics Cloud Services is positioned to deliver peace of mind to customers so they can focus on the business of running the laborat
04 May 2020
The Internet of Things is transforming benchtop lab devices into collections of small data sources, which will eventually allow scientists to better understand variances in their research and results.
12 March 2020
Novel Therm has a unique solution that allows it to build low-cost HPC data centres that are powered by low temperature geothermal energy. With its innovative technology, Novel Therm provides 100 per cent green-powered data centres with no upfront customer investment and at significantly lower cost than competitors can offer. Learn how in this white paper.
Pages
Latest issue
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
